From January 1, 2027, certain insurers would cover yearlong supplies of covered hormone therapy; Medicaid would cover medically necessary hormone therapy and prescribed contraception where federal law allows.
Certain policies covering hormone therapy would pay for a year's supply at once, excluding GLP-1 drugs. Smaller supplies and legal limits on controlled drugs would apply.
Medicaid would cover a year's supply of medically necessary hormone therapy where federal law allows, excluding GLP-1 drugs. Smaller supplies and legal limits on controlled drugs would apply.
Medicaid would cover a year's supply of prescribed, federally approved contraception at once where federal law allows. Members or their prescribing providers could request less.
Certain health insurance policies would pay for a twelve-month supply of covered hormone therapy and supplies needed to take it, dispensed at once. This applies to specified individual and group policies that already cover hormone therapy. The drugs must have federal approval and adjust hormones the body is not producing at intended levels, as the prescriber determines. Patients could request less, and prescribers could require less. For controlled drugs, plans would cover the maximum refills legally allowed at once. The drugs called GLP-1 and GLP-1 receptor agonists are excluded. Plans could limit refills in the last quarter if a year's supply was already dispensed that plan year. They could also apply rules controlling drug use where legally allowed. The requirement would apply to covered policies delivered, issued for delivery, renewed, amended, or continued in Connecticut on or after January 1, 2027.
The Connecticut Commissioner of Social Services would provide Medicaid coverage for medically necessary hormone therapy and supplies needed to take it, dispensed as a twelve-month supply at once. This covers Medicaid members whose hormone therapy is medically necessary. The drugs must have federal approval and adjust hormones the body is not producing at intended levels, as the prescriber determines. Coverage would apply only as federal law permits. Members could request less, and prescribers could require less. For controlled drugs, Medicaid would cover the maximum refills legally allowed at once. The drugs called GLP-1 and GLP-1 receptor agonists are excluded. The Medicaid hormone therapy provision would take effect January 1, 2027.
The Connecticut Commissioner of Social Services would provide Medicaid coverage for a twelve-month supply of prescribed contraception dispensed at once. This covers Medicaid members with prescriptions for contraceptive drugs, devices, or products approved by the United States Food and Drug Administration. Coverage would apply only as federal law permits. The Medicaid member or prescribing health care provider could request less than a twelve-month supply. The Medicaid contraception provision would take effect January 1, 2027.
No hearings or votes scheduled.